The body’s natural cannabinoid system, the endocannabinoid system, plays a major role in regulating anxiety throughout the body. (more…)
Tag Archives: cannabis could disrupt pharmaceutical sales
Analysts have estimated that Epidiolex could be a $1 billion drug for GW Pharmaceuticals. (more…)
Many people have advocated using medical marijuana as an alternative for prescription opioids. But now researchers at the University of Florida will..
Anxiety disorders are the most common mental illness in the US. An estimated 40 million American adults, or just over 18%..
Hemp businesses are closely watching as the drug Epidiolex, made by GW Pharmaceuticals, moves through the FDA approval pipeline. (more…)
Many older adults use marijuana to help with chronic pain, an ailment that becomes more common with age. Others use..
Research into the potential medical uses of marijuana compounds continues apace. Among the most recent, a study delved into why..
British cannabis-derived medicines company GW Pharma is planning to gear up its plant growing and processing operations in the UK..
Pharmaceutical companies are intrigued by the immense and growing medical marijuana market but cannot figure a way to corner it...
The largest survey on cannabidiol or CBD usage to date found that women were more likely than men to use..
The U.S. Food and Drug Administration (FDA) recently granted orphan drug approval for Chrysoeriol, a cannabis-based drug used to treat acute..
If drops in prescription drug use seen in states with legalized marijuana were duplicated the nationwide, Big Pharma would feel..
